Inactive Instrument

Redwood Pharma AB Stock

REDW

SE0021512134

Latest news: Redwood Pharma AB

24-07-29	Redwood Pharma to File for Bankruptcy in Stockholm	MT
24-07-29	Redwood Pharma files for bankruptcy	FW
24-06-26	Redwood Pharma has not received any offers with attractive terms	FW
24-06-12	Redwood Pharma Provides an Update on the Process for Divesting the Company's Assets	CI
24-06-12	Redwood Pharma moves forward with asset divestment process - expected to be completed in July	FW
24-05-22	Redwood Pharma Provides Update on Process to Divest Assets	CI
24-05-08	Redwood Pharma AB's Product RP501 attracted a lot of interest at ARVO in Seattle	CI
24-05-07	Two International Companies Begin Due Diligence on Redwood Pharma AB's Product RP501 Ahead of Potential Commercial Agreements	CI
24-05-06	Redwood Pharma - Interview with board member Håkan Magnusson	FW
24-04-23	Redwood Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-02-15	Redwood Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
23-12-19	Redwood Pharma proposes reverse split 1:100	FW
23-11-23	Redwood Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

More news

Analysts' recommendations: Redwood Pharma AB

23-08-25

Analyst Group sees long-term value in Redwood Pharma's business

More recommendations

Press Releases: Redwood Pharma AB

24-07-28	Redwood Pharma files for bankruptcy	AQ
24-06-26	Redwood Pharma provides a new update regarding divestment of company assets	AQ
24-06-12	Redwood Pharma provides an update on the process for divesting the company's assets	AQ
24-05-23	Redwood Pharma provides an update on the company's future	AQ
24-05-08	Redwood Pharma's product RP501 attracted a lot of interest at ARVO in Seattle	AQ

More press releases

Managers and Directors: Redwood Pharma AB

Manager	Title	Age	Since
Hans Ageland COO	Chief Operating Officer	65	2012-01-19
Martin Vidaeus CEO	Chief Executive Officer	60	2012-01-19
Ulf Björklund CTO	Chief Tech/Sci/R&D Officer	70	2015-12-31

Director	Title	Age	Since
Martin Vidaeus BRD	Director/Board Member	60	2012-01-19
Ulf Björklund CHM	Chairman	70	2022-12-31
Tom Juhani Rönnlund BRD	Director/Board Member	53	2023-05-31

More insiders

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REDWOOD PHARMA AB	+4.41%	-1.25%	-	-	320K
MERCK & CO., INC.	+1.79%	+3.21%	+83.41%	+40.07%	369B
MERCK KGAA	+0.41%	+1.64%	+21.78%	-16.43%	66.12B
HALOZYME THERAPEUTICS, INC.	-0.89%	+3.25%	+43.23%	+179.25%	12.65B
KYOWA KIRIN CO., LTD.	-0.29%	+1.37%	-4.00%	-15.28%	7.5B
SK BIOPHARMACEUTICALS CO., LTD.	-0.13%	-1.90%	-31.63%	-10.80%	4.42B
YUHAN CORPORATION	-0.40%	-4.42%	-36.26%	+8.44%	4.1B
BETTA PHARMACEUTICALS CO., LTD.	+4.64%	+5.71%	-26.33%	-8.42%	3.1B
SUPERNUS PHARMACEUTICALS, INC.	+1.86%	+3.11%	-7.08%	+54.83%	2.49B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+2.77%	+2.54%	-21.46%	-33.39%	1.98B
Average	+1.41%	+2.06%	+2.41%	+22.03%	52.36B
Weighted average by Cap.	+1.46%	+2.89%	+68.53%	+33.70%

See all sector performances

Redwood Pharma AB is a Sweden-based company, which is primarily focused on pharmaceutical industry. The Company develops IntelliGel, a patented hydrogel drug delivery platform technology. IntelliGel is a patented supramolecular smart drug delivery system with an ability to dissolve water-insoluble and sparingly soluble drugs, or disperse, suspend and stabilize otherwise insoluble drugs. It is an odor-free, clear and transparent hydrogel with low solid content, and forms an invisible patch when applied to a surface. The Companyâ€™s development product is focused on treatment of chronic Dry Eye Disease (DED) in post-menopausal women. It is based on a naturally occurring, endogenous molecule found in the body.

Employees

Sector

Pharmaceuticals

More about the company